Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05579509 · ClinicalTrials.gov registry record · Early Phase 1
Personalizing Preprocedural Sedation for Regional Anesthesia
A Early Phase 1 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 82
- Enrollment target
NCT05579509 is a Early Phase 1 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 82 participants.
The verdict
NCT05579509, a Early Phase 1 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 82 participants
- Enrollment target
Study Summary
This is a prospective, randomized study in patients who receive a nerve block prior to surgery. The aim is to investigate whether individual differences in psychosocial and pain profiles may play a role in how patients experience sedation for regional anesthesia. The study will utilize a mixed-methods approach, including a randomized controlled intervention and semi-structured interviews, in order to systematically investigate the relationship between an individual patient's level of catastrophizing and efficacy of procedural sedation, while exploring patient satisfaction with the preoperative nerve block experience.
Interventions
- DRUG Midazolam and Fentanyl
- BEHAVIORAL Educational Reassurance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2022-10-22 |
| Est. Completion | 2024-05-24 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05579509
The ClinicalTrials.gov registry entry for NCT05579509 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam and Fentanyl is the first listed.
NCT05579509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05579509 about?
NCT05579509 is a clinical study titled "Personalizing Preprocedural Sedation for Regional Anesthesia". This is a prospective, randomized study in patients who receive a nerve block prior to surgery. The aim is to investigate whether individual differences in psychosocial and pain profiles may play a role in how patients experience sedation for regional anesthesia. The study will utilize a mixed-metho...
What is the current status of trial NCT05579509?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 82 participants. The study started on 2022-10-22. Estimated completion is 2024-05-24.
What interventions are being tested in trial NCT05579509?
The interventions under investigation include: Midazolam and Fentanyl (DRUG), Educational Reassurance (BEHAVIORAL).
Who is sponsoring clinical trial NCT05579509?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.